Disease-Targeted Sequencing of Ion Channel Genes identifies de novo mutations in Patients with Non-Familial Brugada Syndrome-Reference-Cited by-同舟云学术

Disease-Targeted Sequencing of Ion Channel Genes identifies de novo mutations in Patients with Non-Familial Brugada Syndrome

Published:2014-10-23 Issue:1 Volume:4 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Juang Jyh-Ming Jimmy,Lu Tzu-Pin,Lai Liang-Chuan,Ho Chia-Chuan,Liu Yen-Bin,Tsai Chia-Ti,Lin Lian-Yu,Yu Chih-Chieh,Chen Wen-Jone,Chiang Fu-Tien,Yeh Shih-Fan Sherri,Lai Ling-Ping,Chuang Eric Y.,Lin Jiunn-Lee

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep06733.pdf

Reference41 articles.

1. Straus, S. M. et al. The incidence of sudden cardiac death in the general population. J Clin Epidemiol 57, 98–102 (2004).

2. Priori, S. G. et al. Task Force on Sudden Cardiac Death, European Society of Cardiology. Europace 4, 3–18 (2002).

3. Brugada, P. & Brugada, J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20, 1391–6 (1992).

4. Mizusawa, Y. & Wilde, A. A. Brugada syndrome. Circ Arrhythm Electrophysiol 5, 606–16 (2012).

5. Berne, P. & Brugada, J. Brugada syndrome 2012. Circ J 76, 1563–71 (2012).

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Slack K+ channels confer protection against myocardial ischaemia/reperfusion injury;Cardiovascular Research;2024-08-05

2. Neurocardiac pathologies associated with potassium channelopathies;Epilepsia;2024-08

3. Genetic and clinical characteristics of catecholaminergic polymorphic ventricular tachycardia in a Taiwanese nationwide cohort;Journal of the Formosan Medical Association;2024-08

4. The cardiac blood transcriptome predicts de novo onset of atrial fibrillation in heart failure;Journal of Molecular and Cellular Cardiology Plus;2024-06

5. Therapeutic Targeting of Potassium Channels;Ion Channels as Targets in Drug Discovery;2024